Evidence map›Paper›PMID 21486766›Full record

ArticleThe Journal of physiology2011

The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation.

S-Y Chan, A Martín-Santos, L S Loubière, A M González, B Stieger, A Logan, C J McCabe, J A Franklyn, M D Kilby

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 59 citations in OpenAlex.

  1. Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Thyroid Hormone Transporters in Pregnancy and Fetal Development.International journal of molecular sciences · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Expression profiles and association between OATP4A1 and PGEInternational journal of clinical and experimental pathology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Biological functions of thyroid hormone in placenta.International journal of molecular sciences · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

S-Y ChanSchool of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Floor 3, Birmingham Women's Hospital, Edgbaston, Birmingham B15 2TG, UK. s.chan@bham.ac.uk
A Martín-Santos
L S Loubière
A M González
B Stieger
A Logan
C J McCabe
J A Franklyn
M D Kilby
University of Birmingham · GBBirmingham Women's Hospital · GBUniversity Hospital of Zurich · CH

Funding

Medical Research Council G0501548Medical Research Council G0700089Medical Research Council G9900837Wellcome Trust
6 · The paper itself

Abstract

Associations of neurological impairment with mutations in the thyroid hormone (TH) transporter, MCT8, and with maternal hypothyroxinaemia, suggest that THs are crucial for human fetal brain development. It has been postulated that TH transporters regulate the cellular supply of THs within the fetal brain during development. This study describes the expression of TH transporters in the human fetal cerebral cortex (7–20 weeks gestation) and during retinoic acid induced neurodifferentiation of the human N-Tera-2 (NT2) cell line, in triiodothyronine (T3) replete and T3-depleted media. Compared with adult cortex, mRNAs encoding OATP1A2, OATP1C1, OATP3A1 variant 2, OATP4A1, LAT2 and CD98 were reduced in fetal cortex at different gestational ages, whilst mRNAs encoding MCT8, MCT10, OATP3A1 variant 1 and LAT1 were similar. From the early first trimester, immunohistochemistry localised MCT8 and MCT10 to the microvasculature and to undifferentiated CNS cells. With neurodifferentiation, NT2 cells demonstrated declining T3 uptake, accompanied by reduced expressions of MCT8, LAT1, CD98 and OATP4A1. T3 depletion significantly reduced MCT10 and LAT2 mRNA expression at specific time points during neurodifferentiation but there were no effects upon T3 uptake, neurodifferentiation marker expression or neurite lengths and branching. MCT8 repression also did not affect NT2 neurodifferentiation. In conclusion, many TH transporters are expressed in the human fetal cerebral cortex from the first trimester, which could regulate cellular TH supply during early development. However, human NT2 neurodifferentiation is not dependent upon T3 or MCT8 and there were no compensatory changes to promote T3 uptake in a T3-depleted environment.

Indexed as

Aborted FetusAmino Acid Transport Systems, NeutralAmino Acid Transport System y+Carrier ProteinsCell DifferentiationCell LineCerebral CortexFusion Regulatory Protein-1Fusion Regulatory Protein 1, Light ChainsGene ExpressionGestational AgeHumansIntermediate Filament ProteinsLarge Neutral Amino Acid-Transporter 1Monocarboxylic Acid TransportersNerve Tissue ProteinsAmino Acid Transport Systems, NeutralAmino Acid Transport System y+Carrier ProteinsFusion Regulatory Protein-1Fusion Regulatory Protein 1, Light ChainsIntermediate Filament ProteinsLarge Neutral Amino Acid-Transporter 1Monocarboxylic Acid TransportersNerve Tissue ProteinsNES protein, humanNestinNeurofilament ProteinsOctamer Transcription Factor-3Organic Anion TransportersPOU5F1 protein, humanRNA, Small InterferingSLC16A10 protein, humanSLC16A2 protein, humanSLC7A8 protein, humanSymportersThyroid HormonesTretinoinTriiodothyronine

Identifiers

PMID21486766
PMCPMC3112558
OpenAlexW1512446190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.